002868 *ST绿康生化
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)107.180-231.086-44.056-18.570-3.513
总资产报酬率 ROA (%)-4.057-25.739-13.843-9.762-2.335
投入资产回报率 ROIC (%)-6.358-35.795-17.344-11.494-2.706

边际利润分析
销售毛利率 (%)5.877-8.367-8.960-2.80516.398
营业利润率 (%)-19.937-65.913-46.574-40.552-9.103
息税前利润/营业总收入 (%)-10.509-56.732-39.929-36.357-7.924
净利润/营业总收入 (%)-19.909-68.678-43.908-37.205-7.277

收益指标分析
经营活动净收益/利润总额(%)91.74650.86770.51665.07127.972
价值变动净收益/利润总额(%)-5.012-2.160-4.7457.54663.560
营业外收支净额/利润总额(%)0.4880.0301.9770.261-2.252

偿债能力分析
流动比率 (X)0.1430.1740.5141.0430.584
速动比率 (X)0.0630.0970.2970.8590.427
资产负债率 (%)105.820101.64578.92651.66442.624
带息债务/全部投入资本 (%)95.04188.48463.93038.91028.049
股东权益/带息债务 (%)-10.176-3.01742.843144.949240.113
股东权益/负债合计 (%)-5.622-1.73226.51992.995133.792
利息保障倍数 (X)-1.103-6.166-5.265-8.454-8.095

营运能力分析
应收账款周转天数 (天)34.85644.48850.83155.19636.903
存货周转天数 (天)63.30676.12594.80379.76367.978